Working… Menu

Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04480138
Recruitment Status : Recruiting
First Posted : July 21, 2020
Last Update Posted : January 28, 2021
Information provided by (Responsible Party):
Cadila Healthcare Limited

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 15, 2021
Estimated Study Completion Date : May 30, 2021